Arcutis Biotherapeutics director Howard G. Welgus reports $133,140.48 share sale
ARQT•Director Howard G. Welgus sold 4,728 Arcutis Biotherapeutics shares at $28.16 each on Nov. 16, 2026, and exercised options for 4,094 shares. His direct holdings totaled 34,573 shares after the transactions.
1. Share transactions
Welgus sold 4,728 common shares at $28.16 each on Nov. 16, 2026. He also exercised stock options for 4,094 common shares at exercise prices of $6.5223, $7.51 and $8.63. His direct common stock holdings totaled 34,573 shares following the transactions.




